Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer (Q44711344)

5 December 2017

title

Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer (English)

1 reference

5 December 2017

Lisa Rydén

1

1 reference

5 December 2017

Barbro Linderholm

2

1 reference

5 December 2017

Niels Hilmer Nielsen

3

1 reference

5 December 2017

Stefan Emdin

4

1 reference

5 December 2017

Per-Ebbe Jönsson

5

1 reference

5 December 2017

Göran Landberg

6

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Breast Cancer Research and Treatment

5 December 2017

published in

1 reference

5 December 2017

volume

82

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

147-154

1 reference

https://scigraph.springernature.com/pub.10.1023/b:brea.0000004357.92232.cb

5 December 2017

exact match

0 references

cites work

Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

Estrogen receptors and long-term prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Validation of tissue microarray technology in breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer--results of the analysis of 670 patients with 11 years of follow-up

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Prognostic value of estrogen receptors in primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Why do so many prognostic factors fail to pan out?

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Molecular mediators of tumor angiogenesis: Enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

VEGFs, receptors and angiogenesis

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000004357.92232.CB

7 January 2021

10.1023/B:BREA.0000004357.92232.CB

Identifiers

DOI

1 reference

Dimensions Publication ID

5 December 2017

1013598070

0 references

1 reference